Mind + Muscle

technical minds + legal muscle


dig deep

One More Hurdle Cleared - Amgen's Preliminary Injunction Motion for Filgrastim is Denied

  • 03.23.15
  • Paul A. Calvo, Ph.D. & Timothy J. Shea, Jr.

On March 19, 2015, Judge Seeborg of the United States District Court for the Northern District of California denied Amgen Inc.’s motion for a preliminary injunction in the Amgen v. Sandoz case, thereby removing one more hurdle for the market entry of the first biosimilar in the United States. This current dispute hinges on the interpretation of two portions of subsection 42 U.S.C. § 262(l) of the Biologics Price Competition and Innovation Act.

Read more from Paul A. Calvo, Ph.D. and Timothy J. Shea, Jr. in the attached pdf.

Related People

Related Industries

Sort By Media Type

Sort By Media Type
  • AlertAlert
  • BriefsBriefs
  • Comments to USPTOComments to USPTO
  • Design Patent Case DigestDesign Patent Case Digest
  • MultimediaMultimedia
  • News & ArticlesNews & Articles
  • Press ReleasePress Release
  • VideoVideo
  • WebinarWebinar

Unsolicited e-mails and information sent to Sterne, Kessler, Goldstein & Fox P.L.L.C. will not be considered confidential or privileged, may be disclosed to others, may not receive a response, and do not create an attorney-client relationship with Sterne Kessler.  If you are not already a client of Sterne Kessler, do not include any confidential information in this message.